Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Nephrology · HNF1B-related disease

Orientation: Understanding Your HNF1B Diagnosis

At a Glance

HNF1B-related disease is a genetic condition that most often affects the kidneys but can also affect blood sugar, the pancreas, liver, reproductive tract, and learning or development. Symptoms vary widely, so genetic results guide personalized monitoring rather than predict one fixed outcome.

Receiving a diagnosis of HNF1B-related disease often brings a mix of emotions. For some, it is the end of a long “diagnostic odyssey”—a period of searching for answers to unexplained kidney cysts or blood sugar issues. For others, it may feel overwhelming to learn that a single genetic change can affect multiple parts of the body.

This condition goes by several names, which can be confusing. HNF1B-related disease is the umbrella term. You may also hear about ADTKD-HNF1B (the kidney disease aspect), MODY5 (the diabetes aspect), or 17q12 deletion syndrome (a larger chromosomal deletion that includes HNF1B) [1]. While the names are complex, they all describe a condition where a specific instruction manual in the body—the HNF1B gene—is either missing or changed.

What is HNF1B?

The HNF1B gene is a master controller that tells the body how to build and operate several organs while a baby is developing in the womb [2]. Because this gene is active in many places, the condition is multisystemic, meaning it can affect:

  • Kidneys: This is the most common feature. It can cause cysts, small kidneys, or structural abnormalities present from birth [3].
  • Pancreas: The pancreas may be smaller than usual, which can lead to early-onset diabetes or trouble digesting food [4][5].
  • Liver: Some people have abnormal liver enzyme levels or structural changes in the bile ducts [6].
  • Reproductive Tract: In some individuals, the reproductive system may develop differently [7][8].

Two Ways the Gene Changes

There are two primary ways this condition occurs. Both are autosomal dominant, meaning only one changed copy of the gene is needed to cause the condition [9].

  1. 17q12 Deletion: A small piece of chromosome 17 is missing. This includes the entire HNF1B gene plus neighboring genes [10]. Because more genes are missing, people with this deletion are more likely to have neurodevelopmental features, such as learning challenges or autism, compared to those with a single gene mutation [11].
  2. Intragenic HNF1B Mutation: The chromosome is intact, but there is a specific pathogenic sequence variant (a “typo”) within the HNF1B gene itself [2].

In certain referral cohorts, these two types each account for roughly half of the diagnosed cases, though frequencies vary depending on who is tested. Interestingly, some observational studies suggest that kidney disease progression may be slower on average in those with the 17q12 deletion, but this is a group trend—a deletion-versus-mutation result cannot by itself predict an individual’s course [12].

A Spectrum of Outcomes

The most important thing to understand about this diagnosis is variable expressivity. This means that even people in the same family with the exact same genetic change can have very different symptoms [13][14].

  • Kidney Health: Some children are born with visible kidney abnormalities but maintain stable kidney function for many years. Others may see a gradual decline in function [2][15].
  • Diabetes: Not everyone with an HNF1B change develops diabetes. While it is common, it often appears later in adolescence or adulthood, though it can occasionally be seen in early childhood [4][12].
  • The “Unexpected” Diagnosis: Sometimes, a parent is diagnosed only after their child is tested. The parent may have lived their whole life with a mild form of the condition without ever knowing there was a genetic cause [13].

Managing the Uncertainty

It is natural to feel anxious about the “what ifs” of a variable diagnosis. Care usually involves a multidisciplinary team, including nephrologists (kidney doctors), endocrinologists (diabetes doctors), and geneticists [16].

Knowing the genetic cause allows your doctors to move from “watching and waiting” to proactive monitoring—checking blood pressure, magnesium levels, blood sugar, and kidney function before problems arise [2][17]. While the diagnosis may be complex, it provides a roadmap for personalized care.

Common questions in this guide

What is HNF1B-related disease?
It is a genetic condition caused by a change in one copy of the HNF1B gene or by a 17q12 deletion that includes the gene. It most often affects kidney development or function but may also affect the pancreas, blood sugar, liver, reproductive tract, or learning and development.
What is the difference between an HNF1B mutation and a 17q12 deletion?
An HNF1B sequence variant changes part of the HNF1B gene, while a 17q12 deletion removes the whole gene and nearby genes. Because a deletion affects more genetic material, learning challenges or autism may be more common, but either result can have a wide range of effects.
Does HNF1B-related disease always worsen kidney function or cause diabetes?
Not necessarily. Some people have kidney abnormalities but stable function for many years, while others have a gradual decline; diabetes is common but not universal and often begins in adolescence or adulthood. The same genetic result cannot predict exactly what will happen to one person.
What should be monitored after an HNF1B diagnosis?
Care may include regular checks of blood pressure, magnesium, blood sugar, and kidney function, with additional evaluation based on the organs affected. A coordinated team that may include nephrology, endocrinology, and genetics can adjust monitoring as findings change.
Should my relatives have genetic testing for HNF1B?
HNF1B-related disease is autosomal dominant, so one changed copy can cause the condition and a parent or other biological relative may also carry it. A genetics professional can review the result, discuss which relatives may benefit from testing, and explain what the findings mean.

Get notified when new evidence is published on HNF1B-related autosomal dominant tubulointerstitial kidney disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    17q12 Deletion Syndrome as a Rare Cause for Diabetes Mellitus Type MODY5.

    Roehlen N, Hilger H, Stock F, et al.

    The Journal of clinical endocrinology and metabolism 2018; (103(10)):3601-3610 doi:10.1210/jc.2018-00955.

    PMID: 30032214
  2. 2

    Variable Expressivity of HNF1B Nephropathy, From Renal Cysts and Diabetes to Medullary Sponge Kidney Through Tubulo-interstitial Kidney Disease.

    Izzi C, Dordoni C, Econimo L, et al.

    Kidney international reports 2020; (5(12)):2341-2350 doi:10.1016/j.ekir.2020.09.042.

    PMID: 33305128
  3. 3

    Hypomagnesemia as First Clinical Manifestation of ADTKD-HNF1B: A Case Series and Literature Review.

    van der Made CI, Hoorn EJ, de la Faille R, et al.

    American journal of nephrology 2015; (42(1)):85-90 doi:10.1159/000439286.

    PMID: 26340261
  4. 4

    Diabetes, Associated Clinical Spectrum, Long-term Prognosis, and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1B (HNF1B) Molecular Defects.

    Dubois-Laforgue D, Cornu E, Saint-Martin C, et al.

    Diabetes care 2017; (40(11)):1436-1443 doi:10.2337/dc16-2462.

    PMID: 28420700
  5. 5

    Clinical characteristics of HNF1B-related disorders in a Japanese population.

    Nagano C, Morisada N, Nozu K, et al.

    Clinical and experimental nephrology 2019; (23(9)):1119-1129 doi:10.1007/s10157-019-01747-0.

    PMID: 31131422
  6. 6

    New-onset diabetes after kidney transplantation revealing HNF1B-associated disease.

    Lopes AM, Teixeira S

    Endocrinology, diabetes & metabolism case reports 2021; (2021()).

    PMID: 33522494
  7. 7

    Fetal anomalies associated with HNF1B mutations: report of 20 autopsy cases.

    Duval H, Michel-Calemard L, Gonzales M, et al.

    Prenatal diagnosis 2016; (36(8)):744-51 doi:10.1002/pd.4858.

    PMID: 27297286
  8. 8

    Primary male factor infertility due to asthenospermia in maturity-onset diabetes of the young type 5 (MODY 5): uncommon presentation of an uncommon disease.

    Chakraborty PP, Patra S, Biswas SN, Barman H

    BMJ case reports 2018; (2018()) doi:10.1136/bcr-2017-223723.

    PMID: 29574432
  9. 9

    Autosomal dominant tubulointerstitial kidney disease in Chinese patients.

    Li MS, Jiang L, You RL, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2026; (41(6)):1045-1057 doi:10.1093/ndt/gfaf229.

    PMID: 41143746
  10. 10

    MODY5 and 17q12 Microdeletion Syndrome: Phenotype Variability, Prenatal and Postnatal Counseling.

    Fontana P, Costabile C, Falco M, et al.

    Genes 2025; (16(9)) doi:10.3390/genes16091002.

    PMID: 41009948
  11. 11

    Review of neurodevelopmental disorders in patients with HNF1B gene variations.

    Nittel CM, Dobelke F, König J, et al.

    Frontiers in pediatrics 2023; (11()):1149875 doi:10.3389/fped.2023.1149875.

    PMID: 36969268
  12. 12

    Renal and Extrarenal Phenotypes in Patients With HNF1B Variants and Chromosome 17q12 Microdeletions.

    Buffin-Meyer B, Richard J, Guigonis V, et al.

    Kidney international reports 2024; (9(8)):2514-2526 doi:10.1016/j.ekir.2024.05.007.

    PMID: 39156164
  13. 13

    Hepatocyte Nuclear Factor 1 Beta Mutation-associated Newborn Onset of Glomerulocystic Kidney Disease: A Case Presentation.

    Goknar N, Ekici Avci M, Uckardes D, et al.

    Medeniyet medical journal 2021; (36(4)):352-355 doi:10.4274/MMJ.galenos.2021.02686.

    PMID: 34939403
  14. 14

    Management of adults with Alagille syndrome.

    Ayoub MD, Bakhsh AA, Vandriel SM, et al.

    Hepatology international 2023; (17(5)):1098-1112 doi:10.1007/s12072-023-10578-x.

    PMID: 37584849
  15. 15

    Improving renal phenotype and evolving extra-renal features of 17q12 deletion encompassing the HNF1B gene.

    Cleper R, Reches A, Shapira D, et al.

    Translational pediatrics 2021; (10(12)):3130-3139 doi:10.21037/tp-21-386.

    PMID: 35070826
  16. 16

    Spectrum of Genetic T-Cell Disorders from 22q11.2DS to CHARGE.

    Urschel D, Hernandez-Trujillo VP

    Clinical reviews in allergy & immunology 2022; (63(1)):99-105 doi:10.1007/s12016-022-08927-z.

    PMID: 35133619
  17. 17

    Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia.

    Wang Y, Xiao X, Lin Q, et al.

    Journal of diabetes investigation 2024; (15(1)):121-130 doi:10.1111/jdi.14084.

    PMID: 37737534

This overview of HNF1B-related disease is for informational purposes only and does not constitute medical advice. A nephrologist, endocrinologist, or genetics professional can interpret your or your child's result and tailor monitoring.